Regulatory factor X-associated ankyrin- containing protein
AltitudeomicsDB
Protein Official symbol |
RFXANK |
Aliases |
RFXANK ANKRA1 RFXB |
Chromosomal Location |
19 |
Length |
260 |
Uniprot ID |
O14593 |
EC number |
None |
Protein family Information(Pfam) |
PF12796;PF13606; |
PDB id |
3UXG;3V30;6MEW; |
InterPro ID |
IPR002110;IPR020683;IPR036770;IPR017362; |
dbSNP |
rs34282046 rs751386365 rs1802498 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
RFXANK |
RFX5 |
0.998 |
RFX5 |
RFXAP |
0.998 |
RFXANK |
HDAC4 |
0.997 |
CIITA |
RFX5 |
0.992 |
RFX7 |
RFXANK |
0.989 |
RFXANK |
HDAC5 |
0.985 |
RFXANK |
RFXAP |
0.982 |
CIITA |
RFXANK |
0.966 |
CIITA |
RFXAP |
0.948 |
HDAC4 |
HDAC5 |
0.931 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
8625 (RFXANK) |
5993 (RFX5) |
4261 (CIITA) |
64864 (RFX7) |
9759 (HDAC4) |
5994 (RFXAP) |
10014 (HDAC5) |
8625 (RFXANK)
|
1.00
|
0.49
|
0.37
|
0.62
|
0.18
|
0.77
|
0.18
|
5993 (RFX5)
|
0.49
|
1.00
|
0.58
|
0.80
|
0.63
|
0.74
|
0.62
|
4261 (CIITA)
|
0.37
|
0.58
|
1.00
|
0.30
|
0.65
|
0.56
|
0.67
|
64864 (RFX7)
|
0.62
|
0.80
|
0.30
|
1.00
|
0.32
|
0.64
|
0.35
|
9759 (HDAC4)
|
0.18
|
0.63
|
0.65
|
0.32
|
1.00
|
0.34
|
0.87
|
5994 (RFXAP)
|
0.77
|
0.74
|
0.56
|
0.64
|
0.34
|
1.00
|
0.33
|
10014 (HDAC5)
|
0.18
|
0.62
|
0.67
|
0.35
|
0.87
|
0.33
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
RFXANK |
Human |
Blood |
- |
3650 m |
48 hours |
downregulated |
0.698 |
Microarray |
Himalayas |
Indians |
1 |
HAPE Pateints Vs Normal |
http://medind.nic.in/iab/t12/i1/iabt12i1p1.pdf |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
8625 |
GO:0003712 |
transcription cofactor activity |
GOTERM_MF_DIRECT |
8625 |
GO:0007265 |
Ras protein signal transduction |
GOTERM_BP_DIRECT |
8625 |
GO:0006357 |
regulation of transcription from RNA polymerase II promoter |
GOTERM_BP_DIRECT |
8625 |
GO:0003700 |
transcription factor activity |
GOTERM_MF_DIRECT |
8625 |
GO:0005634 |
nucleus |
GOTERM_CC_DIRECT |
8625 |
GO:0005737 |
cytoplasm |
GOTERM_CC_DIRECT |
8625 |
GO:0003677 |
DNA binding |
GOTERM_MF_DIRECT |
8625 |
GO:0006351 |
transcription |
GOTERM_BP_DIRECT |
8625 |
GO:0045171 |
intercellular bridge |
GOTERM_CC_DIRECT |
8625 |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
GOTERM_BP_DIRECT |
8625 |
GO:0005654 |
nucleoplasm |
GOTERM_CC_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
8625 |
hsa04612 |
Antigen processing and presentation |
8625 |
hsa05152 |
Tuberculosis |
8625 |
hsa05340 |
Primary immunodeficiency |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
RFXANK |
8625 |
Bare lymphocyte syndrome 2 |
C2931418 |
Disease or Syndrome |
0.64 |
0.681 |
0.483 |
disease |
RFXANK |
8625 |
Bare Lymphocyte Syndrome, Type II, Complementation Group D |
C1859537 |
Disease or Syndrome |
0.3 |
0.681 |
0.483 |
disease |
RFXANK |
8625 |
Bare Lymphocyte Syndrome, Type II, Complementation Group B |
C1859535 |
Disease or Syndrome |
0.4 |
0.681 |
0.483 |
disease |
RFXANK |
8625 |
Bare Lymphocyte Syndrome, Type II, Complementation Group A |
C1859534 |
Disease or Syndrome |
0.3 |
0.681 |
0.483 |
disease |
RFXANK |
8625 |
Bare Lymphocyte Syndrome, Type II, Complementation Group E |
C1859538 |
Disease or Syndrome |
0.3 |
0.681 |
0.483 |
disease |
RFXANK |
8625 |
Bare Lymphocyte Syndrome, Type II, Complementation Group C |
C1859536 |
Disease or Syndrome |
0.3 |
0.681 |
0.483 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |